4.8 Editorial Material

Longevity-relevant regulation of autophagy at the level of the acetylproteome

期刊

AUTOPHAGY
卷 7, 期 6, 页码 647-649

出版社

LANDES BIOSCIENCE
DOI: 10.4161/auto.7.6.15191

关键词

aging; cancer; Caenorhabditis elegans; HCT116; Saccharomyces cerevisiae; SILAC

向作者/读者索取更多资源

The acetylase inhibitor, spermidine and the deacetylase activator, resveratrol, both induce autophagy and prolong life span of the model organism Caenorhabditis elegans in an autophagy-dependent fashion. Based on these premises, we investigated the differences and similarities in spermidine and resveratrol-induced autophagy. The deacetylase sirtuin 1 (SIRT1) and its orthologs are required for the autophagy induction by resveratrol but dispensable for autophagy stimulation by spermidine in human cells, Saccharomyces cerevisiae and C. elegans. SIRT1 is also dispensable for life-span extension by spermidine. Mass spectrometry analysis of the human acetylproteome revealed that resveratrol and/or spermidine induce changes in the acetylation of 560 peptides corresponding to 375 different proteins. Among these, 170 proteins are part of the recently elucidated human autophagy protein network. Importantly, spermidine and resveratrol frequently affect the acetylation pattern in a similar fashion. In the cytoplasm, spermidine and resveratrol induce convergent protein de-acetylation more frequently than convergent acetylation, while in the nucleus, acetylation is dominantly triggered by both agents. We surmise that subtle and concerted alterations in the acetylproteome regulate autophagy at multiple levels.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Anatomy & Morphology

Spermidine supplementation influences mitochondrial number and morphology in the heart of aged mice

Jil Messerer, Christoph Wrede, Julia Schipke, Christina Brandenberger, Mahmoud Abdellatif, Tobias Eisenberg, Frank Madeo, Simon Sedej, Christian Muhlfeld

Summary: Aging is associated with dysfunctional mitochondria, and spermidine treatment can normalize the number and morphology of mitochondria in aged hearts.

JOURNAL OF ANATOMY (2023)

Review Immunology

Local anesthetics and immunotherapy: a novel combination to fight cancer

Lucillia Bezu, Oliver Kepp, Guido Kroemer

Summary: Intratumoral injection of oncolytic agents or local administration of non-viral oncolytic therapies can activate an anticancer immune response, while local anesthetics injected into malignant lesions also possess antineoplastic effects. Combining local anesthetics with immune checkpoint inhibition can significantly improve overall survival. The molecular and cellular mechanisms underlying the combination therapy's efficacy are summarized.

SEMINARS IN IMMUNOPATHOLOGY (2023)

Article Cell Biology

Microglial phagocytosis dysfunction in stroke is driven by energy depletion and induction of autophagy

Sol Beccari, Virginia Sierra-Torre, Jorge Valero, Marta Pereira-Iglesias, Mikel Garcia-Zaballa, Federico N. Soria, Laura De Las Heras-garcia, Alejandro Carretero-Guillen, Estibaliz Capetillo-Zarate, Maria Domercq, Paloma R. Huguet, David Ramonet, Ahmed Osman, Wei Han, Cecilia Dominguez, Travis E. Faust, Omar Touzani, Olatz Pampliega, Patricia Boya, Dorothy Schafer, Guillermo Marino, Emmanuelle Canet-Soulas, Klas Blomgren, Ainhoa Plaza-Zabala, Amanda Sierra

Summary: The dysfunction of microglial phagocytosis, resulting in impaired engulfment and degradation, is found in stroke and other brain disorders. This dysfunction is not explained by transcriptional changes but is related to energy depletion triggered by oxygen and nutrient deprivation. Modulating microglial autophagy may be a potential therapeutic strategy for stroke and other brain disorders.

AUTOPHAGY (2023)

Article Cell Biology

Poly(ADP-ribose) polymerase-1 and its ambiguous role in cellular life and death

Maria Castedo, Antoine Lafarge, Guido Kroemer

Summary: Deletion or inhibition of the PARP1 gene protects mice against cerebral ischemia and Parkinson's disease, while PARP1 inhibitors are used to eradicate vulnerable cancer cells. Excessive activation of PARP1 is involved in a specific cell death pathway called parthanatos, and inhibition of PARP1 in cancer cells amplifies DNA damage to a lethal level. Therefore, PARP1 plays a context-dependent role in cell fate decisions. Additionally, PARP1 appears to have an ambiguous role in organismal aging.

CELL STRESS (2023)

Review Cell Biology

G-quadruplex ligands as potent regulators of lysosomes

Lucille Ferret, Karla Alvarez-Valadez, Jennifer Riviere, Alexandra Muller, Natalia Bohalova, Luo Yu, Lionel Guittat, Vaclav Brazda, Guido Kroemer, Jean-Louis Mergny, Mojgan Djavaheri-Mergny

Summary: Guanine-quadruplex structures (G4) are formed by guanine-rich DNA and RNA sequences and control gene expression mechanisms. G4 ligands have been developed for potential therapeutic applications in human diseases. Recent evidence suggests that G4 ligands may target cellular components such as lysosomes and mitochondria.

AUTOPHAGY (2023)

Review Cardiac & Cardiovascular Systems

Hallmarks of cardiovascular ageing

Mahmoud Abdellatif, Peter P. Rainer, Simon Sedej, Guido Kroemer

Summary: In this Review, Kroemer and colleagues summarize eight molecular hallmarks of cardiovascular ageing, including disabled macroautophagy, loss of proteostasis, genomic instability, epigenetic alterations, mitochondrial dysfunction, cell senescence, dysregulated neurohormonal signalling and inflammation. Targeting these hallmarks therapeutically can attenuate residual cardiovascular risk in older individuals.

NATURE REVIEWS CARDIOLOGY (2023)

Article Multidisciplinary Sciences

Peripheral modulation of antidepressant targets MAO-B and GABAAR by harmol induces mitohormesis and delays aging in preclinical models

Luis Filipe Costa-Machado, Esther Garcia-Dominguez, Rebecca L. McIntyre, Jose Luis Lopez-Aceituno, Alvaro Ballesteros-Gonzalez, Andrea Tapia-Gonzalez, David Fabregat-Safont, Tobias Eisenberg, Jesus Gomez, Adrian Plaza, Aranzazu Sierra-Ramirez, Manuel Perez, David Villanueva-Bermejo, Tiziana Fornari, Maria Isabel Loza, Gonzalo Herradon, Sebastian J. Hofer, Christoph Magnes, Frank Madeo, Janet S. Duerr, Oscar J. Pozo, Maximo-Ibo Galindo, Isabel del Pino, Riekelt H. Houtkooper, Diego Megias, Jose Vina, Mari Carmen Gomez-Cabrera, Pablo J. Fernandez-Marcos

Summary: Reversible mitochondrial stress, known as mitohormesis, improves mitochondrial function and delays aging. In this study, harmol, a beta-carboline compound, was found to induce mitohormesis in peripheral organs, alleviate aging-related phenotypes in mice, and extend lifespan in invertebrate models.

NATURE COMMUNICATIONS (2023)

Article Nutrition & Dietetics

Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment

Julia Martin-Virgala, Sara Fernandez-Villabrille, Beatriz Martin-Carro, Isaac Tamargo-Gomez, Juan F. Navarro-Gonzalez, Carmen Mora-Fernandez, Laura Calleros, Elena Astudillo-Cortes, Noelia Avello-Llano, Guillermo Marino, Adriana S. Dusso, Cristina Alonso-Montes, Sara Panizo, Jorge B. Cannata-Andia, Manuel Naves-Diaz, Natalia Carrillo-Lopez

Summary: This study investigated the potential role of sKlotho as an early biomarker in Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD). The findings indicated that sKlotho is a reliable indicator of kidney alpha-Klotho and may protect against osteogenic differentiation by increasing autophagy. Further studies are needed to explore the mechanisms of this potential protective effect.

NUTRIENTS (2023)

Article Cell Biology

Changes in Liver Lipidomic Profile in G2019S-LRRK2 Mouse Model of Parkinson's Disease

Yaiza Corral Nieto, Sokhna M. S. Yakhine-Diop, Paula Moreno-Cruz, Laura Manrique Garcia, Amanda Gabrielly Pereira, Jose A. Morales-Garcia, Mireia Niso-Santano, Rosa A. Gonzalez-Polo, Elisabet Uribe-Carretero, Sylvere Durand, Maria Chiara Maiuri, Marta Paredes-Barquero, Eva Alegre-Cortes, Saray Canales-Cortes, Adolfo Lopez de Munain, Jordi Perez-Tur, Ana Perez-Castillo, Guido Kroemer, Jose M. Fuentes, Jose M. Bravo-San Pedro

Summary: Using mass spectrometry, this study identified metabolic changes in the liver of mouse models of Parkinson's disease, with the aim of finding new peripheral biomarkers for diagnosis.
Review Oncology

Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy

Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, Guido Kroemer, Jennifer A. Wargo, Nicola Segata, Laurence Zitvogel

Summary: Many studies have identified Gut OncoMicrobiome Signatures (GOMS) as biomarkers for predicting immune-checkpoint inhibitor (ICI) efficacy. There is an association between oncogenesis and intestinal dysbiosis, and GOMS are shared between patients with various cancer subtypes and individuals with chronic inflammatory disorders. This review discusses these patterns, presents findings from a meta-analysis of GOMS associated with clinical benefit from ICIs, and proposes practical guidelines for incorporating GOMS in decision-making in immuno-oncology.

NATURE REVIEWS CLINICAL ONCOLOGY (2023)

Editorial Material Oncology

A mitochondrial checkpoint to adaptive anticancer immunity

Oliver Kepp, Peng Liu, Guido Kroemer, Lorenzo Galluzzi

Summary: BCL2 robustly maintains mitochondrial integrity, inhibits immune signaling and cell death, and limits the ability of dendritic cells to initiate adaptive immune responses, suggesting a universal immunosuppressive function for the mitochondrial immune checkpoint.

ONCOIMMUNOLOGY (2023)

Article Oncology

Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses

Shuai Zhang, Liwei Zhao, Mengfei Guo, Peng Liu, Sijing Li, Wei Xie, Ai-Ling Tian, Jonathan G. Pol, Hui Chen, Hui Pan, Misha Mao, Yumei Li, Laurence Zitvogel, Yang Jin, Oliver Kepp, Guido Kroemer

Summary: This study identified two small molecule drugs, ikarugamycin and astemizole, with immunotherapeutic potential. Ikarugamycin acts on DCs to enhance their antigen presenting ability, while astemizole activates T cells to strengthen immune response. Both drugs improved the anticancer activity of oxaliplatin.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Review Biochemistry & Molecular Biology

The BCL2 inhibitor venetoclax mediates anticancer effects through dendritic cell activation

Peng Liu, Liwei Zhao, Laurence Zitvogel, Oliver Kepp, Guido Kroemer

Summary: The BCL2 inhibitor venetoclax and genetic BCL2 inhibition exert their anticancer effects indirectly by enhancing the immune stimulatory function of dendritic cells and increasing tumor immunosurveillance through a T cell-mediated immune response.

CELL DEATH AND DIFFERENTIATION (2023)

暂无数据